文献速递神经免疫认知障碍与痴呆

抗GluK2抗体脑炎:突出小脑受累及抗体内化机制

Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2.
PubMed 文献 · Ann Neurol · 2021-05-17

该研究在8例类似大鼠脑免疫染色的患者血清中鉴定出抗红藻氨酸受体亚基2(GluK2)抗体,并采用细胞法检测596例神经系统疾病患者及23例健康对照,发现GluK2抗体与突出临床-影像学小脑受累的脑炎相关,抗体效应主要为GluK2内化。

要点

  • GluK2抗体相关脑炎常表现为突出的小脑受累,部分可致梗阻性脑积水。
  • 在抗AMPAR或抗NMDAR脑炎患者中也可检出GluK2抗体,提示重叠可能。
  • 抗体通过内化GluK2并可逆性减少GluK2介导电流发挥致病作用。

核心结论

  • GluK2抗体与一种突出临床-影像学小脑受累的脑炎相关,抗体效应主要由GluK2内化介导。

研究设计与样本

  • 研究用2例患者血清从神经元培养物中沉淀抗原,并以表达GluK2的HEK293细胞建立细胞法检测596例不同神经疾病患者和23例健康对照。
  • 通过免疫沉淀、GluK2免疫吸收、GluK2敲除脑组织免疫组化及电生理等方法验证抗体特异性和效应。

主要发现

  • 8例患者中6例发生急性脑炎,具有突出小脑受累的临床或MRI特征,其中4例表现为小脑炎,2例因此导致梗阻性脑积水。
  • 8例中2例抗体与GluK1或GluK3中存在的额外GluK2表位反应,经GluK2免疫吸收后反应均消除。
  • 1例样本对AMPAR和NMDAR有轻度反应,据此在抗AMPAR脑炎患者中检出5/71例、抗NMDAR脑炎患者中检出1/73例携带GluK2抗体。
  • GluK2抗体在HEK293细胞和神经元中诱导GluK2内化,该效应在神经元中可逆。
  • 在抗体介导GluK2内化时间框架内,经患者GluK2血清处理的细胞中GluK2介导电流显著降低。

关键数值与推荐

  • 细胞法检测显示8例类似大鼠脑免疫染色患者血清可沉淀GluK2,并经多种方法确认抗体特异性。
  • 在596例不同神经疾病患者中,抗AMPAR脑炎患者GluK2抗体阳性率为5/71,抗NMDAR脑炎患者为1/73。

临床怎么用

  • 对突出小脑受累的脑炎患者,尤其伴小脑炎或梗阻性脑积水表现时,应考虑检测GluK2抗体。
  • 在抗AMPAR或抗NMDAR脑炎患者中亦需警惕GluK2抗体共存的可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to report the identification of antibodies against the glutamate kainate receptor subunit 2 (GluK2-abs) in patients with autoimmune encephalitis, and describe the clinical-immunological features and antibody effects. METHODS: Two sera from 8 patients with similar rat brain immunostaining were used to precipitate the antigen from neuronal cultures. A cell-based assay (CBA) with GluK2-expressing HEK293 cells was used to assess 596 patients with different neurological disorders, and 23 healthy controls. GluK2-ab effects were determined by confocal microscopy in cultured neurons and electrophysiology in GluK2-expressing HEK293 cells. RESULTS: Patients' antibodies precipitated GluK2. GluK2 antibody-specificity was confirmed by CBA, immunoprecipitation, GluK2-immunoabsorption, and GluK2 knockout brain immunohistochemistry. In 2 of 8 samples, antibodies reacted with additional GluK2 epitopes present in GluK1 or GluK3; in both, the reactivity was abrogated after GluK2 immuno-absorption. Six of 8 patients developed acute encephalitis and clinical or magnetic resonance imaging (MRI) features of predominant cerebellar involvement (4 presenting as cerebellitis, which in 2 patients caused obstructive hydrocephalus), and 2 patients had other syndromes (1 with cerebellar symptoms). One of the samples showed mild reactivity with non-kainate receptors (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors [AMPAR] and N-methyl-D-aspartate receptors [NMDAR]) leading to identify 6 additional cases with GluK2-abs among patients with anti-AMPAR (5/71) or anti-NMDAR encephalitis (1/73). GluK2-abs internalized GluK2 in HEK293 cells and neurons; these antibody-effects were reversible in neurons. A significant reduction of GluK2-mediated currents was observed in cells treated with patients' GluK2 serum following the time frame of antibody-mediated GluK2 internalization. INTERPRETATION: GluK2-abs associate with an encephalitis with prominent clinicoradiological cerebellar involvement. The antibody effects are predominantly mediated by internalization of GluK2. ANN NEUROL 2021;90:107-123.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Landa J, Guasp M, Míguez-Cabello F, et al. Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2. Ann Neurol. 2021. PMID: 33949707. doi:10.1002/ana.26098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。